Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Univariate results for FOCM/TS metabolites and vitamin E, folate, ferritin, B12, MMA, and MTHFR status Metabolite | Test | ASD-M (mean ± std)N = 30 | TD-M(mean ± std)N = 29 | p-Values | FDR | AUC | Ratio (ASD-M/TD-M): Vitamin D3‡ | t= | 27.1 ± 9.10 | 24.9 ± 6.08 | 0.27 | 1.00 | 0.57 | 1.09

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Altered metabolism of mothers of young children with Autism Spectrum Disorder: a case control study

Source: Article title.

Finally, participants were invited to share the study advertisement with their network of friends.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Altered metabolism of mothers of young children with Autism Spectrum Disorder: a case control study

Case-control study · BMC Pediatrics · 2020

Original publication title

Altered metabolism of mothers of young children with Autism Spectrum Disorder: a case control study

Kathryn Hollowood-Jones; James B. Adams; Devon M. Coleman; Sivapriya Ramamoorthy; Stepan Melnyk; S. Jill James; Bryan K. Woodruff; Elena L. Pollard; Christine L. Snozek; Uwe Kruger; Joshua Chuah; Juergen Hahn

© The Author(s) 2020

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Mothers of children with ASD have many significantly different metabolite levels compared to mothers of typically developing children at 2 to 5 years after birth.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Previous research studies have demonstrated abnormalities in the metabolism of mothers of young children with autism.

Source: Background

Abstract: What methods does the paper describe?

Metabolic analysis was performed on blood samples from 30 mothers of young children with Autism Spectrum Disorder (ASD-M) and from 29 mothers of young typically-developing children (TD-M). Targeted metabolic analysis focusing on the folate one-carbon metabolism (FOCM) and the transsulfuration pathway (TS) as well as broad metabolic analysis were performed. Statistical analysis of the data involved both univariate and multivariate statistical methods.

Source: Methods

Abstract: Results

Univariate analysis revealed significant differences in 5 metabolites from the folate one-carbon metabolism and the transsulfuration pathway and differences in an additional 48 metabolites identified by broad metabolic analysis, including lower levels of many carnitine-conjugated molecules.

Multivariate analysis with leave-one-out cross-validation allowed classification of samples as belonging to one of the two groups of mothers with 93% sensitivity and 97% specificity with five metabolites. Furthermore, each of these five metabolites correlated with 8 to 15 other metabolites indicating that there are five clusters of correlated metabolites. In fact, all but 5 of the 50 metabolites with the highest area under the receiver operating characteristic curve were associated with the five identified groups. Many of the abnormalities appear linked to low levels of folate, vitamin B12, and carnitine-conjugated molecules.

Source: Results Source: Results

Abstract: Conclusions

Mothers of children with ASD have many significantly different metabolite levels compared to mothers of typically developing children at 2 to 5 years after birth.

Source: Conclusions
Authors’ abstract

Background

Previous research studies have demonstrated abnormalities in the metabolism of mothers of young children with autism.

Methods

Metabolic analysis was performed on blood samples from 30 mothers of young children with Autism Spectrum Disorder (ASD-M) and from 29 mothers of young typically-developing children (TD-M). Targeted metabolic analysis focusing on the folate one-carbon metabolism (FOCM) and the transsulfuration pathway (TS) as well as broad metabolic analysis were performed. Statistical analysis of the data involved both univariate and multivariate statistical methods.

Results

Univariate analysis revealed significant differences in 5 metabolites from the folate one-carbon metabolism and the transsulfuration pathway and differences in an additional 48 metabolites identified by broad metabolic analysis, including lower levels of many carnitine-conjugated molecules.

Multivariate analysis with leave-one-out cross-validation allowed classification of samples as belonging to one of the two groups of mothers with 93% sensitivity and 97% specificity with five metabolites. Furthermore, each of these five metabolites correlated with 8 to 15 other metabolites indicating that there are five clusters of correlated metabolites. In fact, all but 5 of the 50 metabolites with the highest area under the receiver operating characteristic curve were associated with the five identified groups. Many of the abnormalities appear linked to low levels of folate, vitamin B12, and carnitine-conjugated molecules.

Conclusions

Mothers of children with ASD have many significantly different metabolite levels compared to mothers of typically developing children at 2 to 5 years after birth.

Publication and source details

Original title: Altered metabolism of mothers of young children with Autism Spectrum Disorder: a case control study

Kathryn Hollowood-Jones; James B. Adams; Devon M. Coleman; Sivapriya Ramamoorthy; Stepan Melnyk; S. Jill James; Bryan K. Woodruff; Elena L. Pollard; Christine L. Snozek; Uwe Kruger; Joshua Chuah; Juergen Hahn

BMC Pediatrics · 2020

© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/100000057National Institute of General Medical Sciences5T32GM067545-13Hollowood-Jones Kathryn http://dx.doi.org/10.13039/100000060National Institute of Allergy and Infectious DiseasesR01AI110642Hahn Juergen http://dx.doi.org/10.13039/100007332Autism Research InstituteWomen in Philanthropy Program at Arizona State University

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T13:50:36.887679+00:00

DOI: 10.1186/s12887-020-02437-7 · PMC7734806